FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of March, 2003
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
Enclosure: Holding(s) in Company released 18 March, 2003
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Celltech Group plc
2. Name of shareholder having a major interest
Aviva plc and Morley Fund Management Limited
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18
As in 2 above
4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
BNY Norwich Union Nominees Ltd 2,509,236
BT Globenet Nominees Ltd 5,500
Chase GA Group Nominees Ltd 5,140,759
Chase Nominees Ltd 698,777
CUIM Nominee Ltd 2,925,612
RBSTB Nominees Ltd 297,074
5. Number of shares / amount of stock acquired
580,298
6. Percentage of issued class
0.21%
7. Number of shares / amount of stock disposed
N/a
8. Percentage of issued class
N/a
9. Class of security
Ordinary 50p Shares
10. Date of transaction
14 March 2003
11. Date company informed
18 March 2003
12. Total holding following this notification
11,576,958
13. Total percentage holding of issued class following this notification
4.2%
14. Any additional information
15. Name of contact and telephone number for queries
Anita Dowling
(01753) 777106
16. Name and signature of authorised company official responsible for making this notification
Anita Dowling
Date of notification
18 March 2003
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not accept any
liability for error or omission. The FSA is not liable for any damages (including, without limitation, damages for loss of business
or loss of profits) arising in contract, tort or otherwise from the use of or inability to use this document, or any material
contained in it, or from any action or decision taken as a result of using this document or any such material.
END
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 18 March, 2003